Biocon stake sale

Biocon completes 10% stake sale in Syngene

Biotechnology major Biocon on Monday concluded sale of 10 percent stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company Private Ltd.

Jan 12, 2015, 19:26 PM IST